--- title: "Kovack Advisors Inc. Has $2.33 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG" description: "Kovack Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 382.1% in Q3, owning 5,211 shares valued at $2.33 million. Other investors also boosted their positions, with Toba" type: "news" locale: "en" url: "https://longbridge.com/en/news/276449055.md" published_at: "2026-02-20T13:51:11.000Z" --- # Kovack Advisors Inc. Has $2.33 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG > Kovack Advisors Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 382.1% in Q3, owning 5,211 shares valued at $2.33 million. Other investors also boosted their positions, with Tobam increasing its stake by 666.7%. Intuitive Surgical's stock opened at $499.53, with a market cap of $177.40 billion and a P/E ratio of 63.31. The company reported Q4 earnings of $2.53 per share, exceeding estimates, and revenue of $2.87 billion, up 18.8% year-over-year. Analysts have mixed ratings, with price targets ranging from $560 to $714. Kovack Advisors Inc. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 382.1% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 5,211 shares of the medical equipment provider's stock after buying an additional 4,130 shares during the period. Kovack Advisors Inc.'s holdings in Intuitive Surgical were worth $2,331,000 as of its most recent filing with the SEC. Get **Intuitive Surgical** alerts: - Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors Several other large investors have also recently bought and sold shares of the stock. Tobam grew its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at $27,000. Riggs Asset Managment Co. Inc. increased its position in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock worth $38,000 after buying an additional 32 shares during the period. Finally, First Command Advisory Services Inc. lifted its holdings in shares of Intuitive Surgical by 3,750.0% during the second quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider's stock worth $42,000 after buying an additional 75 shares in the last quarter. 83.64% of the stock is owned by institutional investors. ## Intuitive Surgical Price Performance ISRG stock opened at $499.53 on Friday. The company has a 50 day simple moving average of $536.64 and a 200 day simple moving average of $510.37. The stock has a market cap of $177.40 billion, a price-to-earnings ratio of 63.31, a P/E/G ratio of 3.88 and a beta of 1.65. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $608.16. - Intuitive Surgical Just Proved the Growth Engine Still Runs Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter last year, the business posted $2.21 earnings per share. The company's quarterly revenue was up 18.8% on a year-over-year basis. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year. ## Insider Transactions at Intuitive Surgical In other Intuitive Surgical news, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the transaction, the director directly owned 3,694 shares in the company, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 56,189 shares of company stock worth $30,785,441 in the last 90 days. 0.70% of the stock is currently owned by company insiders. ## Analyst Ratings Changes - 2 Healthcare Names That Could Get a Big Boost From Earnings Several equities analysts recently commented on ISRG shares. Argus decreased their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating on the stock in a research note on Wednesday, February 4th. Truist Financial increased their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a "buy" rating in a research report on Thursday, December 18th. The Goldman Sachs Group reiterated a "buy" rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. HSBC boosted their price target on Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research note on Monday, January 26th. Finally, Sanford C. Bernstein raised their price objective on Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a research note on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $617.23. **Check Out Our Latest Stock Report on Intuitive Surgical** ## Intuitive Surgical Profile (Free Report) Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room. In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers. ## Recommended Stories - Five stocks we like better than Intuitive Surgical - Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why - Elon Taking SpaceX Public! $100 Pre-IPO Opportunity! - Unlocked: Elon Musk’s Next Big IPO - My Epstein Story - NEW LAW: Congress Approves Setup For Digital Dollar? **Want to see what other hedge funds are holding ISRG?** Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report). *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Intuitive Surgical Right Now? Before you consider Intuitive Surgical, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list. While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [IHI.US - iShares US Medical Devices](https://longbridge.com/en/quote/IHI.US.md) - [ISUL.US - GraniteShares 2x Long ISRG Daily ETF](https://longbridge.com/en/quote/ISUL.US.md) - [XHE.US - SPDR S&P Health Equip](https://longbridge.com/en/quote/XHE.US.md) - [ISRG.US - Intuitive Surgical](https://longbridge.com/en/quote/ISRG.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Intuitive Surgical, Inc. $ISRG Shares Sold by Cercano Management LLC | Cercano Management LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.6% in Q3, owning 9,235 share | [Link](https://longbridge.com/en/news/276209025.md) | | $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today | Intuitive Surgical (NASDAQ:ISRG) has delivered an average annual return of 20.44% over the past 20 years, outperforming | [Link](https://longbridge.com/en/news/271673917.md) | | Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026 | William Blair analyst Brandon Vazquez has maintained a Buy rating on Intuitive Surgical (ISRG) stock, citing its durable | [Link](https://longbridge.com/en/news/273504284.md) | | Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026 \| NNOX Stock News | Nanox Imaging Ltd. will showcase its Nanox.ARC digital tomosynthesis system live in Europe for the first time at the Eur | [Link](https://longbridge.com/en/news/276128373.md) | | BUZZ-Street View: Medtronic's early-stage product cycle strength evident, analysts say | Medtronicexceeded Wall Street's Q3 profit and revenue expectations, driven by strong heart device demand, but maintained | [Link](https://longbridge.com/en/news/276231714.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.